drugset / Trial / NCT02352753
Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI
NaSequentialOpen-labelTreatment
Summary
This is a prospective, multicenter, single-arm study in children 2 to 17 years of age with OI to evaluate efficacy and safety of denosumab.
Timeline
- Start
- 2015-06-24
- Primary completion
- 2022-03-26
- Completion
- 2022-03-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Denosumab | Monoclonal antibody | 1 mg/kg | Subcutaneous |